Gut Microbiota May Influence Eating Behavior, Paving the Way for New Obesity Treatments Recent research suggests that gut microbiota could play a significant role in shaping eating behaviors, potentially leading …
Pharmacology
-
-
Lactate and Lactylation Play Key Roles in Pancreatic Ductal Adenocarcinoma, Study Reveals Research published in Nature Communications highlights the multifaceted roles of lactate and lactylation in pancreatic ductal adenocarcinoma (PDAC), …
-
New Research Targets Compound 10 to Slow Alzheimer’s Progression Researchers have identified a potential therapeutic candidate, referred to as Compound 10, that shows promise in slowing the progression of Alzheimer’s …
-
Justicia carnea Extract Alleviates Oxidative Stress in Pancreatitis: A Natural Approach to Reducing Inflammation By Dr. Natalie Singh, Board-Certified Internal Medicine Physician & MPH Pancreatitis—a painful and often debilitating inflammatory …
-
Advancements in Thermal Infrared Imaging: A New Frontier for Diagnostic Medicine The landscape of diagnostic medicine is undergoing a significant transformation as non-invasive technologies become more sophisticated. Among these, thermal …
-
GLP-1 Receptor Agonists: A New Frontier in Addiction Treatment? The landscape of addiction medicine is evolving rapidly. As a physician, I have closely followed the clinical impact of GLP-1 receptor …
-
Vitamin B3 and Cancer: Understanding the Complex Link Between Nicotinamide and Skin and Pancreatic Cancers Vitamin B3, specifically in the form of nicotinamide, has long been viewed as a promising …
-
Health
Enlicitide: New Pill Reduces LDL Cholesterol by 60% & May Revolutionize Heart Disease Treatment
New Pill Cuts “Bad” Cholesterol by 60%—A Potential Game Changer in Cardiovascular Disease Prevention A new experimental pill, enlicitide, has demonstrated a significant reduction in low-density lipoprotein (LDL) cholesterol—often referred …
-
Uneven Drug Distribution in Tumors: A New Understanding of Cancer Treatment Variability Inside cancer cells, certain drugs may not behave as expected. Instead of spreading evenly, some develop into trapped …
-
Gut Microbiome May Predict Response to GLP-1 Weight Loss Medications New research highlights the growing understanding of how the gut microbiome influences the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 …